Abbott Laboratories, AbbVie, Eli Lilly, Bristol Myers Squibb, and Gilead Sciences are the top pharmaceutical stocks by trading volume recently, according to MarketBeat. These companies are key players in developing and selling drugs for conditions like autoimmune diseases, diabetes, cancer, and viral infections. Investors watch these stocks for growth potential but must consider risks like clinical trials and regulatory approvals. Their diverse product lines and ongoing research make them significant in the healthcare sector's future.
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by rising demand for rapid diagnostics, AI integration, and precision veterinary medicine, alongside i...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by increasing demand for rapid diagnostics, AI integration, robotic workflows, and a focus on companio...
